Jeewanjot Singh | Drug Discovery | Young Scientist Award

Published on by Young Scientists Awards

Young Scientist Award

Jeewanjot Singh
Researcher Jeewanjot Singh
Affiliation Desh Bhagat University
Country India
Scopus ID 59955293600
Documents 4
Citations 15
h-index 2
Subject Area Drug Discovery
Event International Young Scientists Award
ORCID 0009-0000-6290-9250

Jeewanjot Singh

Desh Bhagat University, India

Jeewanjot Singh is affiliated with Desh Bhagat University, India, and has developed an emerging academic profile in the interdisciplinary field of Drug Discovery. His published research contributes to the understanding of pharmaceutical sciences, medicinal chemistry, and modern approaches used in identifying and optimizing biologically active compounds. According to the available Scopus author metrics, the researcher has produced four indexed publications that have collectively received fifteen citations while maintaining an h-index of two, reflecting the early impact of his scholarly work within specialized research communities.[1]

Abstract

The academic profile of Jeewanjot Singh reflects an emerging contribution to drug discovery and pharmaceutical research through peer-reviewed publications indexed in international scientific databases. His research demonstrates interest in identifying therapeutic compounds, understanding biological mechanisms, and supporting evidence-based pharmaceutical innovation. Although still at an early stage of his research career, the available publication and citation indicators illustrate continuous scholarly engagement and growing international visibility. These achievements form an appropriate foundation for consideration within academic recognition programs that acknowledge promising young researchers.[1]

Keywords

Drug Discovery, Pharmaceutical Sciences, Medicinal Chemistry, Therapeutic Research, Scientific Publications, Scopus Author, Young Researcher, Biomedical Innovation, Research Excellence, International Young Scientists Award.

Introduction

Drug discovery represents one of the most demanding areas of biomedical research because it integrates chemistry, biology, pharmacology, computational science, and clinical knowledge. Researchers working in this discipline contribute to identifying novel therapeutic compounds, improving existing medicines, and addressing global health challenges through systematic scientific investigation. Early-career researchers play an important role in advancing innovative concepts and supporting collaborative research environments. The documented research activities of Jeewanjot Singh illustrate participation in this evolving scientific landscape through internationally indexed publications and measurable scholarly impact.[2]

Research Profile

Jeewanjot Singh is associated with Desh Bhagat University and maintains an internationally indexed Scopus author profile. His research portfolio currently includes four Scopus-indexed documents with fifteen citations and an h-index of two. These metrics indicate developing academic visibility and demonstrate that his publications have attracted attention from researchers working in related scientific disciplines. His ORCID profile further supports transparent researcher identification and facilitates international scholarly collaboration.[1]

Research Contributions

  • Contributed to research associated with modern drug discovery methodologies.
  • Participated in pharmaceutical and medicinal chemistry investigations.
  • Published peer-reviewed research indexed within Scopus.
  • Supported evidence-based scientific communication through internationally accessible publications.

Publications

The available bibliometric information indicates four indexed publications within the field of drug discovery and related pharmaceutical sciences. These publications contribute to the scientific literature through peer-reviewed dissemination and have collectively generated measurable citation activity. Publication records indexed in internationally recognized databases provide evidence of research quality, accessibility, and academic dissemination.[1]

Research Impact

Bibliometric indicators including citation counts and the h-index are widely used to evaluate scholarly influence alongside peer review and research quality. With fifteen citations and an h-index of two, Jeewanjot Singh demonstrates a developing research profile consistent with an emerging investigator. Continued publication activity, collaboration, and citation growth are expected to further strengthen the long-term academic impact of his research contributions.[3]

Award Suitability

Based on publicly available scholarly metrics, indexed publications, and active participation in pharmaceutical research, Jeewanjot Singh demonstrates characteristics commonly associated with emerging scientific excellence. His documented publication record, measurable citation performance, researcher identification through ORCID, and institutional affiliation collectively support eligibility for recognition programs that acknowledge promising early-career scientists. The International Young Scientists Award recognizes scholarly achievement, research quality, innovation, and professional development, making this academic profile relevant for consideration according to published award evaluation criteria.[4]

Conclusion

Jeewanjot Singh has established an emerging research presence within the field of drug discovery through internationally indexed publications and measurable citation performance. His academic activities demonstrate commitment to scientific investigation, knowledge dissemination, and continued professional development. As his publication portfolio expands, additional collaborations and research outputs are expected to further enhance his scholarly visibility. The current academic profile provides a structured overview suitable for institutional recognition, professional documentation, and consideration within international young researcher award programs.

References

  1. Elsevier. (n.d.). Scopus Author Details: Jeewanjot Singh, Author ID 59955293600.
    https://www.scopus.com/authid/detail.uri?authorId=59955293600
  2. Paul, S. et al. (2010). How to improve R&D productivity: the pharmaceutical industry’s grand challenge.
    DOI: https://doi.org/10.1038/nrd3078
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output.
    DOI: https://doi.org/10.1073/pnas.0507655102
  4. International Young Scientists Award. Award Information.
    https://youngscientistawards.com/

Sakshi Priya | Pharmaceutical Chemistry | Young Researcher Award

Published on by Young Scientists Awards

Young Researcher Award

Sakshi Priya
ICFAI University, Jaipur

Sakshi Priya
Affiliation ICFAI University, Jaipur
Country India
Scopus ID 59434148200
Documents 6
Citations 43
h-index 3
Subject Area Pharmaceutical Chemistry
Event International Young Scientists Award
Google Scholar View Profile

Sakshi Priya is associated with ICFAI University, Jaipur, India, and has established a developing research profile in the field of Pharmaceutical Chemistry. Her scholarly work demonstrates an interest in pharmaceutical sciences, medicinal chemistry, and related interdisciplinary areas that contribute to healthcare research. According to indexed academic databases, her publications have received scholarly citations, indicating that her research has been referenced by fellow researchers in relevant scientific disciplines.[1]

Abstract

Sakshi Priya has contributed to the advancement of Pharmaceutical Chemistry through research publications indexed in internationally recognized databases. Her work reflects an emphasis on scientific investigation, analytical methodologies, and pharmaceutical applications that support the broader objectives of drug discovery and healthcare innovation. With six indexed publications, forty-three citations, and an h-index of three, her academic profile demonstrates measurable scholarly engagement and a growing influence within her research community.[1]

Keywords

  • Pharmaceutical Chemistry
  • Medicinal Chemistry
  • Drug Development
  • Pharmaceutical Sciences
  • Scientific Research

Introduction

The International Young Scientists Award recognizes emerging researchers whose scholarly activities demonstrate academic quality, research productivity, and future potential. Evaluation generally considers publication quality, citation performance, research significance, and contributions to scientific advancement. Sakshi Priya’s academic profile reflects these characteristics through consistent research activity in Pharmaceutical Chemistry and participation in internationally indexed scholarly publishing.[2]

Research Profile

Her Scopus-author profile records six indexed documents with forty-three citations and an h-index of three. These bibliometric indicators suggest that her publications have achieved academic visibility and have been cited within the scientific literature. Her affiliation with ICFAI University, Jaipur further supports ongoing research activities in pharmaceutical and chemical sciences.[1]

Research Contributions

Her research contributions focus on pharmaceutical chemistry, emphasizing scientific approaches that may assist in improving pharmaceutical formulations, medicinal compounds, and analytical investigations. Published studies contribute to the growing body of literature supporting pharmaceutical innovation and evidence-based scientific practices. The combination of peer-reviewed publications and scholarly citations indicates meaningful participation in academic research dissemination.[3]

Publications

The research record currently includes six Scopus-indexed publications covering topics related to pharmaceutical chemistry and associated scientific disciplines. These publications have collectively received forty-three citations, reflecting recognition and utilization by other researchers. Individual publications include standard DOI identifiers that facilitate long-term accessibility and citation within scholarly communication systems.[3]

Research Impact

Bibliometric indicators provide evidence of measurable research impact. Citation counts demonstrate scholarly engagement, while the h-index reflects both productivity and citation performance. Although still in the early stages of an academic career, the available metrics indicate a developing research trajectory with continued opportunities for future scientific contributions and collaboration.[1]

Award Suitability

Based on publicly available academic indicators, Sakshi Priya demonstrates characteristics commonly associated with emerging researcher recognition. Her indexed publications, citation record, and active engagement in Pharmaceutical Chemistry provide evidence of scientific productivity and research potential. These achievements align with the objectives of the International Young Scientists Award, which seeks to acknowledge promising early-career researchers making meaningful contributions to their respective disciplines.[2]

Conclusion

Sakshi Priya has established a steadily developing academic profile through peer-reviewed publications, measurable citation performance, and continued research in Pharmaceutical Chemistry. Her scholarly record reflects sustained commitment to scientific inquiry and academic excellence. Based on the available bibliometric evidence and research contributions, her profile represents a competitive example of an emerging researcher suitable for consideration within international academic recognition programs.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Sakshi Priya, Author ID 59434148200.
    https://www.scopus.com/authid/detail.uri?authorId=59434148200
  2. International Young Scientists Award. Award Information.
    https://youngscientistawards.com/
  3. Google Scholar Author Details: Sakshi Priya.
    https://scholar.google.com/citations?user=rzQv2tUAAAAJ&hl=en

Ritik Dixit | Pharmaceutical Chemistry | Young Researcher Award

Published on by Young Scientists Awards

Mr. Ritik Dixit | Pharmaceutical Chemistry | Young Researcher Award

Advance Institute of Biotech & Paramedical Sciences | India

Mr. Ritik Dixit is a promising young researcher in pharmaceutical sciences, focusing on pharmacovigilance, nanodrug delivery, and phytochemical-based therapeutics. He has authored multiple peer-reviewed review articles and academic books, with notable research on Moringa oleifera and advanced drug delivery systems. His research impact is reflected by 59 citations and an h-index of 3. He has also contributed to a glioblastoma-focused book chapter and ongoing herbal formulation research with a patent application. His active participation in conferences and training programs highlights strong academic engagement, making him a suitable candidate for the Young Researcher Award.

Citation Metrics (Scopus)

50

40

30

20

10

0

Citations
31

Documents
4

h-index
1

 


View Scopus Profile View Google Scholar Profile

Featured Publications

Manisha Nidhar | Pharmaceutical Chemistry | Young Scientist Award

Published on by Young Scientists Awards

Dr. Manisha Nidhar | Pharmaceutical Chemistry | Young Scientist Award

Jaipur National University | India

Dr. Manisha Nidhar is an accomplished Associate Professor at the School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, specializing in medicinal chemistry, computer-aided drug design, and the synthesis and biological evaluation of bioactive molecules as antidiabetic agents. She has a strong foundation in synthetic organic chemistry and extensive experience in both teaching and research in pharmaceutical sciences. Her doctoral research at Banaras Hindu University focused on designing and synthesizing bioactive compounds, including pyridazine, pyrazole, β-amino carbonyl, and triazole derivatives, as potential DPP-4 inhibitors for type-2 diabetes, combining laboratory synthesis, purification, and characterization with in-silico studies such as molecular docking, molecular dynamics simulations, and ADMET analyses, followed by comprehensive biological evaluation. Dr. Nidhar has contributed significantly to scientific literature, authoring numerous high-impact publications and book chapters, and has actively participated in workshops, conferences, and faculty development programs on drug design, innovative teaching, and research methodologies. She has guided postgraduate students in designing, synthesizing, and evaluating novel antidiabetic compounds and has played key roles in academic committees and collaborative projects. Proficient in computational tools and scientific software including Chemdraw, Schrodinger, Sybyl, and virtual docking platforms, she excels in scientific information retrieval and reference management. Dr. Nidhar is dedicated to advancing pharmaceutical education and research, combining her passion for teaching and pioneering research to address complex therapeutic challenges. She has 61 citations across 53 documents and an h-index of 5.

Featured Publications

  • Nidhar, M., Khanam, S., Sonker, P., Gupta, P., Mahapatra, A., Patil, S., Yadav, B. K., Singh, R. K., & Tewari, A. K. (2022). Click inspired novel pyrazole-triazole-persulfonimide & pyrazole-triazole-aryl derivatives; Design, synthesis, DPP-4 inhibitor with potential anti-diabetic agents. Bioorganic Chemistry, 120, 105586.

  • Nidhar, M., Sonker, P., Sharma, V. P., Kumar, S., & Tewari, A. K. (2022). Design, synthesis, and in-silico & in vitro enzymatic inhibition assays of pyrazole-chalcone derivatives as dual inhibitors of α-amylase & DPP-4 enzyme. Chemical Papers.

  • Singh, V. P., Nidhar, M., Yadav, P., Kumar, R., Sonker, P., & Tewari, A. K. (2022). Design, synthesis, molecular modeling of heterodimer and inhibitors of α-amylase as hypoglycemic agents. Molecular Diversity.

  • Nidhar, M., Kumar, V., Mahapatra, A., Gupta, P., Sonker, P., et al. (2023). Lead modification on sitagliptin via computational studies; Synthesis of pyrazole containing β-amino carbonyls for the treatment of type-2 diabetes. Chemical Biology and Drug Design, 101(3), 638–649.

  • Nidhar, M., Kumar, V., Mahapatra, A., et al. (2023). Ligand-based designing of DPP-4 inhibitors via hybridization; synthesis, docking, and biological evaluation of pyridazine-acetohydrazides. Molecular Diversity, 27, 2729–2740.